Price $3.35 |
Market Cap
238.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.99
|
P/S
-
|
Dividend %
-
|
|
P/CF
2.9
|
P/FCF
-
|
Op. Cash Flow
-61K
|
FCF
-1.1
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-82.40%
|
ROI
-
|
|
ROA
-60.50%
|
EPS Growth
37.80%
|
Current Ratio
3.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| International Stem Cell Corp (ISCO) | $0.80 | - | - | 6.1M | Strong Buy |
| Daxor Corporation (DXR) | $18.27 | - | - | 62.1M | Strong Buy |
| Digirad Corporation (DRAD) | $2.91 | - | - | 5.8M | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $4.36 | - | - | 1.39B | Strong Buy |
| Diversicare Healthcare Service (DVCR) | $1.67 | - | - | 11.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
